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Executive Summary 
Step Model for Managing Chronic, Non-Malignant Pain in Primary Care 
Problem 
Patients managed in primary care have more opportunity for aberrant behaviors due to the 
additional time and resource requirements needed for careful monitoring and risk mitigation 
(Veterans Administration, 2016).  Not only do primary care providers lack the time to monitor 
patients closely by random drug screening, checking the PDMP, and frequent appointments they 
also lack sufficient training in medical and nursing schools to manage the chronic pain patients 
(Lincoln, Pellico, Kerns, &Anderson, 2013).  This project was selected due to the growing 
opioid crisis.  According to data from the Centers for Disease Control (CDC), from 1999 to 
2015, more than 183,000 people died in the U.S. from overdoses related to prescription opioids 
(CDC, 2017; Rudd, Puja, David & Scholl, 2016).   
Purpose 
Following a thorough literature review, the PICO question was: Will primary care providers who 
prescribe opioids for chronic non-cancer pain provided with an education module and step model 
for managing chronic, non-cancer pain improve their knowledge and confidence and utilize the 
CDC guidelines in managing the chronic non-cancer patient as evidenced by reported 
improvement in knowledge, confidence and improved prescribing practices compared to 
knowledge, confidence, and prescribing practices before the education module and step model? 
Goals 
The project goal was to contribute to nursing practice by utilizing the CDC 
recommendations to help with the opioid epidemic by identifying the educational gap for 
primary care providers with respect to chronic pain management and thereby reducing the 
number of inappropriately prescribed opioids by primary care.   
Objective 
 This project sought to improve provider knowledge and confidence in managing chronic pain 
patients in the primary care setting as well as improving utilization of the CDC guidelines for 
managing chronic pain patients. This was a quality improvement project. 
Plan 
The study design was a quantitative pre-test-post-test design.  The participating primary 
care providers completed a pre-education assessment of their knowledge and confidence levels 
managing chronic pain patients. After the providers completed the online education module and 
had sufficient time to use the step model in treating chronic pain patients, they completed a post-
implementation assessment on their knowledge and confidence levels for comparison, n=7.  
Outcome, Results, and Recommendations 
The intervention made a statistically significant difference in five of the seven questions.  
Question one exhibited the most improvement (Z=21.00, p=.020) indicating a statistically 
significant improvement in their knowledge managing chronic, non-malignant pain (CNMP) in 
their primary care practice.  This project can serve as the framework for additional research on 
the step model with a larger sample size and more nurse practitioner participation. 
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This doctoral project explored the problem recognition and definition, review of 
evidence, project plan and evaluation, findings and results, limitations, recommendations, and 
implications for change; improved knowledge and confidence of primary care providers in 
managing chronic non-cancer pain.   
Problem Recognition and Definition 
Statement of Purpose   
The National Institutes of Health Medline Plus (2011) defines chronic pain as “often 
defined as any pain lasting more than 12 weeks. Whereas acute pain is a normal sensation that 
alerts us to possible injury, chronic pain is very different. Chronic pain persists—often for 
months or even longer…” (p.5-6).  In 2015 report about the prevalence of chronic pain in the 
United States (U.S.) from the National Center for Complimentary and Integrative Health “an 
estimated 25.3 million adults (11.2 percent) experience chronic pain—that is, they had pain 
every day for the preceding 3 months. Nearly 40 million adults (17.6 percent) experience severe 
levels of pain…” (para. 1). According to an article by Daubresse et al. (2013) as cited on the 
Centers for Disease Control (CDC) website,   
From 2007 – 2012, the rate of opioid prescribing has steadily increased among specialists 
 more likely to manage acute and chronic pain. Prescribing rates are highest among pain 
 medicine (49%), surgery (37%), and physical medicine/rehabilitation (36%).  However, 
 primary care providers account for about half of opioid pain relievers dispensed (CDC, 
 2016, para. 2).  
 According to data available from the CDC from 1999 to 2015, more than 183,000 people 
have died in the U.S. from overdoses related to prescription opioids (CDC, 2017; Rudd, Puja, 
David & Scholl, 2016).  The purpose of this project was to provide training on the CDC 
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guidelines for prescribing opioids for chronic pain as well as implementation of a step model for 
primary care providers.   
Problem Statement 
 Primary care providers are unprepared in medical and nursing schools to treat subacute 
and chronic pain (Ponte & Johnson-Tribino, 2005).  There are many non-opioid medications that 
should be prescribed before opioid therapy is initiated (Dowell, Haegerich & Chou, 2016).  
Many primary care providers (PCPs) need guidance when caring for chronic pain patients but 
lack access to pain management specialists (Lincoln, Pellico, Kerns, &Anderson, 2013).   
According to Lincoln, Pellico, Kerns, and Anderson (2013), “PCPs experience substantial 
difficulties in caring for patients with pain while acknowledging certain positive aspects. There is 
a need for strategies that mitigate the barriers to pain management while bolstering the positive 
aspects to improve care and provider satisfaction” (p. 1).   
PICO Question   
 This project utilized the acronym “PICO”, rather than stating a formal research 
hypothesis.  The acronym stands for: The population (P), intervention (I), comparison (C), and 
outcome (O) and is usually framed as question (Melnyk & Fineout-Overhold, 2011). The 
question for this project was as follows: 
P:  Primary care providers who prescribe opioids for chronic non-cancer pain 
I: An education module and step model for managing chronic, non-cancer pain based on the CDC 
guidelines 
C: Knowledge, confidence, and prescribing practices compared to before the education module 
and step model 
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O: As evidenced by reported improvement in knowledge, confidence and improved prescribing 
practices 
Will primary care providers who prescribe opioids for chronic non-cancer pain who are 
provided with an education module and step model for managing chronic, non-cancer pain 
improve their knowledge and confidence in managing the chronic non-cancer patient as 
evidenced by reported improvement in knowledge and confidence compared to knowledge and 
confidence before the education module and step model? 
 The PICO question originates from and specifically relates to the role of the Doctor of 
Nursing Practice (DNP) role as an advanced health care leader with the ability to integrate 
objective data with the knowledge gained from a group’s subjective experience, as well as, the 
ability to apply scientific knowledge to the processes of program development, management, and 
evaluation (Chism, 2010). 
Significance, Scope, and Rational  
This is a quality improvement project aimed to yield several outputs. First, this project 
sought to improve provider knowledge and confidence in managing chronic pain patients in the 
primary care setting. Secondly, chronic pain patients will be managed using CDC guidelines 
improving patient outcomes. Finally, there will be a decrease in inappropriately prescribed 
opioids by primary care providers that will result in a decrease in overall pill burden in 
community and decrease nonmedical use of opioids.  
Theoretical Foundation 
Advanced practice nurses use knowledge from a variety of domains allowing nursing 
practice to develop a full, rich body of knowledge.  According to Zaccagnini and White (2017) 
nursing uses knowledge from many domains including biology, physiology, zoology, medicine, 
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psychology, sociology, physics, mathematics, chemistry, communication, philosophy, and 
theology (p.4).  By utilizing a wide breadth of knowledge, nurses are able to develop knowledge 
that informs nursing practice with a very holistic approach.  The scientific underpinnings of 
nursing knowledge are based on the way nurses view the world as well as how nurses view 
patient care.   
There are several domains that make up the scientific foundations of nursing.  First, the 
philosophical foundation is the base on which nursing knowledge is built.  There are different 
philosophical views but according to Burns and Grove (2001) there are several themes common 
to the nursing profession; holism, quality of life, and the relativity of truth based on each 
person’s perspective.  Zaccagnini and White (2017) other fundamental foundations include 
ethical knowledge, historical knowledge, biophysical and psychosocial knowledge, analytical 
knowledge, and organizational knowledge.   
Scientific research and nursing research is guided by a framework.  This framework 
provides the researcher with “the base from which we seek to understand patients and their 
health problems and from which we plan interventions to help them” (Zaccagnini & White, 
2017, p. 14).   Nursing theory helps the researcher produce higher quality work by providing the 
framework from which we develop a “systematic way to explain or describe nursing practice” 
(Zaccagnini & White, 2017, p. 15).   According to Association of Critical-Care Nurses (AACN), 
“The DNP graduate knows how to integrate nursing science with knowledge from ethics, the 
biophysical, psychosocial, analytical, and organizational sciences as the basis for the highest 
level of nursing practice” (AACN, 2006, p. 9).  
The Synergy Theory was developed by the American Association of Critical-Care Nurses 
(AACN) credentialing arm to better describe nursing practice in 1998.  The Synergy Model 
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describes what nurses do, thus this theory describes the essence of nursing; namely nurses 
undertaking what the patient needs them to do.  The fundamental premise of the theory is 
“patient characteristics drive nurse competencies. When patient characteristics and nurse 
competencies are in synergy, optimal patient outcomes are more apt to occur…” (Curley, 2007, 
p. 25).   
The Synergy Model is a middle range nursing theory. The theory describes eight patient 
characteristics and eight nurse competencies. The patient characteristics that span the continuum 
from health to illness are stability, complexity, vulnerability, predictability, resiliency, 
participation in decision-making, and resource availability (Curley, 2007).  The nursing 
dimensions span from competent to expert are clinical judgment and inquiry, caring practices, 
response to diversity, advocacy/moral agency, facilitation of learning, collaboration, and systems 
thinking (Curley, 2007).  The model proposes optimal patient outcomes occur when the patient 
and the nurse synergize.  The theory requires three levels of outcomes, nurse outcomes, patient 
outcomes, and system outcomes (Curley, 2007).   
There are four assumptions in the synergy model.  First, a holistic view of the person is 
used; mind, body, and spirit.  Second, nurse patient interactions affect each dimension. Third all 
dimensions are considered collectively. And finally, the goal of nursing is to restore the patient 
to health.  The underlying tenants are “patient characteristics are important to nurses, nurses’ 
competencies are important to patients, patient characteristics drive nurse competencies, and 
when patient characteristics and nurses’ competencies match and synergize, outcomes for the 
patient are optimal” (Kaplow & Reed, 2008).   
All of the concepts of the theory are theoretically and operationally defined in, Synergy, 
The Unique Relationship Between Nurses and Patients, the AACN Synergy Model for Patient 
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Care by Martha A. Q. Curley (2007).  The theory is extensively and meticulously defined, and 
examples of outcomes are presented for patient/family, unit, and systems-level outcomes. The 
theory statements are theoretically and operationally defined.  The linkages are explicit and clear.  
The model diagram adds to the clarity of the theory.  The major concepts are represented in the 
model.  The concepts, statements, and assumptions are all used consistently and appropriately in 
the body of text.  The outcomes are predicted based on the context of the interactions.   
The theory is congruent with current nursing standards.  It is a widely utilized theory and 
utilized as the model of AACN certification testing.  The theory is congruent with current 
nursing interventions.  The model is used for patient care in outpatient and inpatient settings, 
professional nursing, staff development, system building, and nursing education.  The model has 
been widely used for nursing practice, research, and education.  In a study by Cypress (2013) the 
model was used to conceptualize the data and served as the framework to recommend practice 
improvements for patients in the emergency room.  This is well researched and vetted theory 
useful for many different areas of research, education, and nursing practice.  
The theory is socially relevant to patients/individuals and families regardless of gender, 
age, or socioeconomic status. The theory has transcultural relevance because it explores the 
relationship between the nurse and the patient irrespective of culture.  
This theory is appropriate to serve as the theoretical framework of this project for several 
reasons.  First, it was used to describe the relationship between the chronic pain patient and the 
advanced practice nurse, thereby helping to guide practice improvement.  Secondly, the theory 
informed the project and helped develop the step model.  Finally, the book authored by Martha 
Curley is very detailed and informative about how to use the model in a variety of different 
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settings such as an ambulatory clinic, as well as nursing practice, patient care, and even within a 
healthcare system.  The theory was informative in most areas of the project.  
Figure 1: Synergy Theory (Curley, 2007) 
 
The second theory to inform this study was the Lewin Change Theory which was 
developed by Kurt Lewin in the 1940’s.  This is a three-stage change model, unfreezing, change, 
refreeze.  Lewin viewed change behavior as a “dynamic balance of forces working in opposing 
directions” (Kritsonis, 2005, p. 1).  The model requires prior learning to be rejected and replaced 
(Petiprin, 2016). 
There are three major concepts, driving forces, restraining forces, and equilibrium.  
Driving forces are forces facilitating change.  Restraining forces are forces that counter the 
driving forces and hider change because they push in the opposite direction.  Equilibrium is a 
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state in which driving forces equal restraining forces to maintain stability and no further changes 
occur (Petiprin, 2016). 
Unfreezing is the process in which an intervention makes it possible for people to change 
an old counterproductive pattern (Petiprin, 2016).   Change, which is also called movement to a 
new level, involves a process with change in thoughts, feelings, behaviors, or all three to a more 
productive state (Petiprin, 2016). Refreezing stage establishes the change with a new norm, or 
the new standard (Petiprin, 2016). 
Review of Evidence 
Systematic Review 
The literature review was performed using the databases CINAHL, Google Scholar, 
Cochrane Database, and PubMed. The initial search reference time frame was August 2016 to 
February 2017. The key words of opioid, chronic pain management, primary care, pain 
management guideline, provider attitude and provider were used.  The level of evidence was 
determined by utilizing a grading system developed by Ackley, Swan, Ladwig  and Tucker 
(2008) (figure 2).  Inclusion criteria were limited to studies in English available electronically 
and limited to the past five years.  After reviewing abstracts, articles were excluded if they did 
not contain clear recommendations for pain management or were not related to primary care 
providers and pain management.  Many articles were found using data mining.   
 The initial searches produced large quantities of literature.  Each was narrowed 
down using Boolean phrases as well as the inclusion criteria listed previously.  The key word 
opioid was searched using Google Scholar yielding  48,400 results, opioid guidance yielded 
22,800 results, and chronic pain yielded 17,100 results.  Primary care attitudes and beliefs about 
opioids yielded 5,530 results, primary care attitudes and beliefs about chronic pain management 
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yielded 6,060 results; opioid step model yielded 17,200 results and opioid stepped care model 
yielded 1,710 results.  Of those searches only three articles were used.   The search in Google 
Scholar yielded many articles not relevant to this project. 
Figure 2:  Literature Grading System  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The key word chronic pain was searched using CINHAL yielding 38,914 results, chronic 
pain management yielded 7,341 results, chronic pain guideline yielded 647 results, opioids 
yielded 23,589 results, opioid guideline yielded 1,360 results, pain management yielded 305 
results, primary care provider plus chronic pain yielded 21 results, primary care provider plus 
chronic pain plus opioid guideline yielded only three results.  A total of 23 publications were 
used from the CINHAL database. 
The key word chronic pain was searched in PUBMED yielding 1,213 results, chronic 
pain management plus opioid guideline yielded 31 results, chronic pain and primary care yielded 
2,016 results, chronic pain plus primary care plus opioid yielded 302 results and chronic pain 
plus primary care plus opioid plus guideline yielded 65 results.  A total of eight publications 
Level of Evidence (LOE) Description 
Level I Evidence from a systematic review or meta-analysis 
of all relevant RCTs (randomized controlled trial) or 
evidence-based clinical practice guidelines based on 
systematic reviews of RCTs or three or more RCTs of 
good quality that have similar results. 
Level II 
Evidence obtained from at least one well-designed 
RCT (e .g. large multi-site RCT). 
Level Ill Evidence obtained from well-designed controlled 
trials without randomization (i.e. quasi-experimental). 
Level IV Evidence from well-designed case-control or cohort 
studies. 
Level V Evidence from systematic reviews of descriptive and 
qualitative studies (meta-synthesis). 
Level VI Evidence from a single descriptive or qualitative 
study. 
Level VII 
Evidence from the opinion of authorities and/or 
reports of expert committees. 
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were used from the PUBMED database.  Overall, a total of 34 articles were used to inform this 
project as listed in table one.  
Table 1: Levels of Evidence   
 
 
 
 
 
 
 
 
 
Evidence and Background 
After a thorough literature review, several themes were identified. These themes 
included: close monitoring, clinical practice guidelines, safeguards, barriers, Prescription Drug 
Monitoring Program, drug testing, and education of providers about pain management (see 
Appendix A: Systematic Review of Literature Sample).  
Ponte and Johnson-Tribino (2005) identified several barriers to managing chronic pain 
patients.  They recognized that caring for pain patients was time consuming and frustrating, 
physicians were fearful of patient harm and scrutiny from regulatory agencies, knowledge gaps, 
and formal medical training did not prepare them to manage pain effectively.  The authors 
concluded the results should be used to expand education for students and practicing providers.   
Levels of Evidence # articles 
Level 1 12 
Level 2 2 
Level 3 0 
Level 4 8 
Level 5 2 
Level 6 2 
Level 7 8 
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Dorflinger et al. (2014) suggested primary care providers use a step model for chronic 
pain treatment help to lower opioid use and increase the use of non-opioid medications, as well 
as the use of complementary approaches to pain management. The research occurred in the 
Veterans’ Administration (VA) Health System and only used electronic health records utilized in 
the VA system however; it illustrates the effectiveness of the intervention and the potential 
usefulness for other populations.  There were no similar studies found that utilized a step model 
for managing chronic pain in the civilian population which highlighted a gap in the literature.   
It is very difficult for a primary care provider to properly monitor a patient who is being 
prescribed opioids.  Their time is very limited for each patient and when they are faced with a 
patient who has complaints of severe, chronic pain they naturally want to help.  According to 
McCrorie et al. (2015), “Problematic prescribing occurs when patients experience repeated 
consultations that do not meet their needs and GPs [General Practitioners] feel unable to 
negotiate alternative approaches to treatment” (p.1).   Without proper monitoring of pain 
patients, it can lead to diversion or addiction. On the other hand, fear of prescribing pain 
medication can leave the patient with untreated pain.  According to Daubresse et al. (2013) 
primary care providers accounted for almost half of opioid pain medications dispensed.  They 
also noted during the years 2000-2010, although prescribing of opioids increased, a similar 
increase in non-opioid medications was not noted. 
Vijayaraghavan, Penko, Guzman, Miaskowski and Kushel (2012) looked at primary care 
providers (PCP) views on chronic pain among high-risk patients, PCPs “reported low confidence 
and satisfaction levels in treating chronic pain” (p.1141).  The study results exposed that PCPs 
are likely to prescribe opioids to current illicit substance abuse patients, highlighting their lack of 
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knowledge concerning opioid therapy.  The low confidence scores and lack of adequate 
education put patients’ lives and the providers’ licenses in danger.  
In a qualitative analysis by Lincoln, Pellico, Kerns, and Anderson (2013) looking at the 
barriers and facilitators to chronic non-cancer pain management in primary care provider’s 
experiences and attitudes, 11 themes were identified.  One of the barriers included inadequate 
training.  Providers who do not feel confident either avoid managing CNMP or may 
inappropriately manage these patients.   
Finally, Ponte and Johnson-Tribino (2005) looked at the attitudes and knowledge about 
pain in West Virginia Family Physicians, “The majority of respondents felt that their formal 
medical training did not prepare them to effectively manage pain” (p. 477).  These articles 
provide insight into why there is such wide variation in provider attitudes about pain 
management and the inconsistencies in managing chronic pain. 
Patients who experience acute pain are often treated first by their primary care providers 
(Lincoln, Pellico, Kerns, &Anderson, 2013).  The pain may be related to recent surgery, injury, 
or disease.  There are many factors contributing to the phenomena of opioid misuse.  Often the 
patients are either undertreated due to provider fear of patient drug addiction and/or lack of 
understanding and fear of federal regulations regarding the prescribing of pain medications 
(Ponte & Johnson-Tribino, 2005). Conversely, patients may be over-treated due to insufficient 
knowledge of treating pain and lack of evidenced based practice guidelines regarding treatment 
of CNMP (Ponte & Johnson-Tribino, 2005).  
Project Plan and Evaluation 
Market/Risk Analyses 
13 
 
 
 
A full market/risk analysis was performed for this project including identifying strengths, 
weaknesses, opportunities and threats in the form of a SWOT analysis (strengths, weakness, 
opportunities, threats).  A SWOT analysis helps the researcher discover and utilize strengths and 
to control and reduce or eliminate weaknesses if possible.  Additionally, there was a full analysis 
of the driving and restraining forces.   
Project strengths, weaknesses, opportunities, threats (SWOT) 
When considering the strengths, weaknesses, opportunities, and threats related to this 
project, there are several things contemplated.  There are several strengths associated with this 
project.  First, this is a subject of great concern and very relevant at this time.  This project was a 
practice improvement project with the potential to directly impact the opioid epidemic in a 
positive manner.  Also, there was very little cost associated with this project. The costs consist of 
time and minimal recourses such as paper and ink.   The research team consisted of committed 
and collaborative members.  The major weakness of this project was the time commitment.  The 
time commitment was great, and the project was implemented while the DNP student was 
working full time.  Further, the expert collaborators and mentor also maintained full time 
employment. Additionally, there was the potential lack of stakeholder buy-in. 
 The opportunities of this project include the fact this is a timely project and the Centura 
Health System reached out to the DNP student about this project.  There is a potential 
opportunity of having this project published in a professional journal and the potential for 
additional research of the step model.  Finally, the threats to this project were the potential lack 
of participation of primary care providers and a limited sample size.  
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Table 2: SWOT Analysis of Capstone Project 
Strengths Weakness 
• Timely, relevant topic 
• Practice improvement 
• Evidenced based interventions 
• Low cost 
• Research team 
• Potential for practice improvement 
• Time commitment DNP student and 
mentor 
• Potential lack of stakeholder buy-in 
Opportunities Threats 
• Centura Health System interest in 
project 
• Potential publication in a 
professional journal 
• Potential for additional research of 
step model 
• Provider participation 
• Limited sample size 
 
Driving/Restraining Forces 
This project had a time line adhered to in order to meet the requirements and deadlines 
set forth by the Regis University DNP program (see Appendix B: Timeline).   This was a driving 
force for this project.  The restraining force was the time commitment as well as provider 
participation.  Finally, the sustaining force was the collaboration of the DNP student and the 
mentor as well as the deadlines set by Regis University.  The DNP student and the mentor met 
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regularly to discuss the project keeping it on a forward trajectory.  The due dates helped keep the 
project moving forward at an anticipated pace. 
Stakeholders and Project Team 
The stakeholders of this project included Centura Health Systems, primary care 
providers, as well as patients.  The benefit of having a tool easily accessible and easily 
comprehended will help with evidenced based management of chronic pain. Additionally, by 
utilizing evidenced based guidelines easy to access and apply should decrease the number of 
opioids prescribed (Doreflinger et al., 2014).  Further, the mentor for this project was contacted 
by the State of Colorado Public Health Department to develop a training module for chronic pain 
management.  If successful, this project could potentially be used for this purpose.   
The project team consists of the DNP student the mentor, Bonnie Wilensky, CNS. Bonnie 
has over 40 years of experience in pain management.  She is considered to be an expert in her 
field.  She has been asked to speak on many occasions for peer to peer trainings as well as 
speaking for pharmaceutical companies about pain management.  She has been an expert witness 
for the Colorado State Board of Nursing.   
The DNP student and the mentor were responsible for development and implementation 
of the project including the step model and educational module.  They were also responsible for 
developing the evaluation tool.  Other members of the team include practicing pain management 
providers, Dr. Leif Sorensen, Dr. Bryan Wernick, and Tina Snyder, DNPc.  They were 
responsible for reviewing the step model and educational module and making recommendations 
before implementation and establishing validity.  The DNP capstone Chair, Cris Finn, PhD, FNP 
worked with the pain management team. 
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Cost-benefit Analysis 
The cost of this project was nominal.  Since the project team based the step model and 
educational module from the CDC guidelines there was very little cost involved other than time. 
The CDC gave permission for the utilization of the guidelines.  There was the cost of coping 
(estimated at 10 cents per page) and purchasing a storage box with locks ($50).  The equipment 
needed to produce the educational module is Power Point software and a computer, which was 
already owned by the DNP student.  The potential benefits of the project far outweigh the 
minimal costs (see Appendix C: Budget).  
The benefit analysis is difficult to determine on a per patient basis.  However, the cost of 
the opioid epidemic is astronomical.  The health and social costs of opioid abuse is 
approximately $55 billion each year in the United States (HHS, 2016).  The cost of emergency 
department and inpatient treatment is approximately $20 billion per year in the United States 
(HHS, 2016).   Most importantly, the benefit of this project is the potential to reduce the number 
of lives lost each year to opioid poisonings.  In 2015 in Colorado, 259 people died from 
prescription opioid overdoses.  That means that in 2015 approximately one Coloradan died every 
36 hours from and opioid overdose (Colorado Department of Healthcare Policy and Finance, 
2017).   There is some good news for Colorado, the number of opioid overdose deaths decreased 
6% in 2016 (Colorado Department of Healthcare Policy and Finance, 2017).  However, heroin 
overdose deaths increased 23% in 2016 (Colorado Department of Healthcare Policy and Finance, 
2017).  How can we put a cost on the value of an abuse free life? Priceless. 
Mission/Vision/Goals 
The mission of this project was to provide education and easily accessible and 
comprehensible guidance for primary care providers in managing chronic, non-cancer pain 
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utilizing the newly updated CDC guidelines.  The vision of the project is to improve provider 
satisfaction in caring for patients with chronic, non-cancer pain as well as improving patient 
outcomes by utilizing best practices. 
According to Terry (2015), the DNP “applies knowledge in the solution of a problem…” 
(p. 16).  The proposed project utilized scholarly works and evidenced based practice 
recommendations to help solve the problem of primary care providers’ decreased knowledge and 
confidence to manage chronic pain patients. The goal of this project was to increase provider 
knowledge and confidence with the implementation of the step model and the education module 
and ultimately evidence to support a need for increased education in pain management for nurse 
practitioners and physicians as the providers. 
The DNP aimed to contribute to nursing practice by utilizing evidenced based practice 
recommendations to help with the opioid epidemic by identifying the education gap for primary 
care providers with respect to chronic pain management and thereby reducing the number of 
opioids prescribed by primary care.  Vijayaraghavan, Penko, Guzman, Miaskowski, and Kushel 
(2012) demonstrate PCP lack of confidence with pain management and need for intervention.  
The authors suggest developing a similar model to the VA model of pain management.  Lincoln, 
Pellico, Kerns, and Anderson (2013) richly describe several themes related to provider views on 
pain management.  The authors discuss inadequacy of education and lack of evidenced based 
guidelines to be used for treatment supporting a gap in the literature. 
Process/Outcomes 
A step model was developed which was easy to follow and available for quick reference 
(Figure 3: Step Model).  Additionally, there was also an online training video for primary care 
providers to access produced by the CDC (see Appendix D: CDC Education Modules).  The 
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project outcomes were improved knowledge and confidence for primary care providers 
managing chronic pain patients, increased understanding and utilization of the CDC guidelines, 
increased provider satisfaction when managing chronic pain patients in the primary care setting, 
and a decrease in the overall prescribed opioids by each provider.  The Step model was sent to 
Dr. Deborah Dowell at the CDC who offered updates and approval for utilization (see Appendix 
E: CDC Response). 
Figure 3: Step Model
 
Logic Model 
According to the W.K. Kellogg Foundation Logic Model Guide (2004) the logic model 
“and its processes facilitate thinking, planning, and communications about program objectives 
and actual accomplishments” (p.III).  The logic model helps the researcher focus on the specific 
areas of planning, design, implementation, analysis, and outcomes (W.K. Kellogg Foundation, 
2004).   The W.K. Kellogg Foundation defines a logic model as “a systematic and visual way to 
present and share your understanding of the relationships among the resources you have to 
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operate your program, the activities you plan, and the changes or results you hope to achieve” 
(W.K. Kellogg Foundation, 2004, p. 1) (see Appendix F: Conceptual Model).   
Through the use of the logic model, key elements of the project were evaluated. There 
were several considerations to be addressed to accomplish the goals for this project. The first 
step was to identify needed resources.  For this project that included identifying evidenced based 
practice guidelines for managing chronic pain.  The CDC developed a comprehensive guideline 
for managing chronic pain (MMRW, 2016) a step model and an education module was 
developed based on those CDC guidelines (Figure 3: Step Model).   
There were several constraints for this project.  The first constraint was the willingness of 
primary care providers to participate in the study.  In order for the study to be meaningful, the 
study required at least 20 participants which was the total available population of primary care 
providers in the research site.  Centura needed to approve the study, be willing to participate, and 
obtain Institutional Review Board (IRB) approval through the Catholic Health Initiative.  
Additionally, the current attitudes and practices of primary care providers may influence their 
willingness to participate.   
Next, the constraints and activities to benchmark targets were identified.  The expected 
outcomes were improved provider knowledge and confidence, improved patient outcomes, and a 
decrease in inappropriately prescribed opioids thereby increasing patient and community safety.  
There were several expected short- and long-term outcomes. First, create a decrease in the 
overall pill burden in the community as well a decrease in nonmedical use of opioids.  Over the 
course of one to three years, the goal is for the step model and education module to be 
implemented in the surrounding communities with state-wide implementation within four to six 
years.  The long-term impact of the project is to illuminate the need to implement focused 
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Population/Sampling/Setting 
In order to define the number of providers needed to determine if the intervention 
produces the expected effect, a power analysis was performed.  Using a calculator from National 
Statistical Service (2017), it was determined to obtain a 95% confidence level with a 0.05 
confidence interval, with an available population of 20 primary care providers, 19 primary care 
providers was required to achieve a 0.80 power.  This will also help to minimize the threat of a 
Type I and Type II errors.   However, using the total available population was ideal.   A type I 
error for this project would be to make a false positive conclusion that the intervention resulted 
in a statistically significant improvement due to sampling fluctuations.   A type II error would be 
a false negative conclusion preventing the implementation of the step model and education 
module.     
According to the World Health Organization (WHO) and the University of Amsterdam 
the sample size for a descriptive study “needs to be large enough to reflect important variations 
in the population, but small enough to allow for intensive study methods” (World Health 
Organization, 2004, p. 65). Having a sample of at least 20 primary care providers was large 
enough to accurately assess the step model using quantitative methods.  Further, since there was 
limited access to primary care providers, the sample size needed to be small. 
The sample size needed for quantitative data generally requires a larger sample size.  In 
order to obtain a 95% confidence level with a 5% margin of error, the total available population 
of primary care providers should be used.  According to Terry (2015) the best course of action is 
to use the entire accessible population since it is under 100.  Participants were recruited through 
a presentation to primary care providers at a hospital in Denver, Colorado.   The setting of the 
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project was in primary care practices in the Centura Health system.   
Protection of Human Subjects 
 The responsibilities of an investigator are to insure all ethical and legal considerations are 
considered before implementing a research study.  “It is the responsibility of each investigator to 
seek review by the IRB for any study involving human subjects prior to beginning the project…” 
(Regis University, 2015, p.5).   The IRB not only protects the human subjects, but also protects 
the researcher from making ethical errors. Regis University’s (RU) policy on using human 
participants’ states: 
Projects such as program evaluation, policy analysis, or quality assurance studies 
 conducted for the purpose of providing information only to the organization studied do 
 not require IRB review, provided they meet the following conditions: (1) They are not 
 intended to produce knowledge that contributes to the general base of human knowledge 
 or publishable; (2) They involve no more than minimal risk as defined in Federal 
 regulations and RU policy; (3) They do not involve vulnerable populations (Regis 
 University, 2015, p. 5).   
According to RU policy, the study was considered a quality improvement project, and 
therefore exempts status through the IRB (see Appendix G: Regis University IRB Exemption 
Letter). The study was also awarded exempt status from Centura Health/Catholic Health 
Initiatives (see Appendix H: Catholic Health Initiative IRB Exemption Letter).  
Additionally, the pre-and post-tests were de-identified and given an assigned number to 
match the pre-test to the post-test.  The key was kept on a password protected computer and the 
completed tests are kept in a locked file cabinet for three years after the completion of the project 
per Regis guidelines (see Appendix I: CITI Certificates). 
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Instrumentation Reliability/Validity and Intended Statistics 
This project used data from a Likert scale, which is ordinal data, obtained from pre-test 
and post-test (intervention) questionnaires from the same participants (see Appendices J: Pre-test 
Questionnaire and K: Post-test Questionnaire) .  The data was evaluated using Wilcoxon Signed 
Ranks Test.  This allowed the data from both groups to be paired for comparison linked by pre-
assigned identifiers.  Arifin (2014) states the goal for pre-post studies is “to determine whether 
there is any significant difference or change in values for a particular numerical variable between 
two occasions for same subjects” (p. e62).  By analyzing the data with the Wilcoxon Signed 
Ranks Test it can be determined if the education module and step model were effective in 
increasing knowledge and confidence of each provider and as a group in managing chronic pain 
patients in the primary care setting.  To measure changing prescribing patterns and practices, 
true/false questions were utilized, which is nominal data.  This data was evaluated using 
descriptive statistics. 
There are several potential threats to validity and reliability that must be addressed.  In a 
pre- and post-test study, the threats to internal validity include selection, maturation, 
mortality/attrition, history, testing, and instrumentation.  Internal validity ensures the 
independent variable caused the change in the dependent variable, meaning the education 
module and step model caused a change in the knowledge and confidence of primary providers 
caring for patients with CNCP.    
When analyzing the data, one thing that must be considered is the possibility other events 
effected the change in the dependent variable other than the independent variable, which is the 
history effect (Polit & Beck, 2017).  By choosing primary care practices in one hospital system, 
it will be easier to monitor for other influencing factors such as required education. Further, the 
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time between pre- and post-test was only four to six weeks to limit exposure to other influencing 
factors.  To control for maturation, which is the change in the dependent variable due to normal 
developmental process, the pre-test Likert scale will determine each individual provider’s 
knowledge and comfort level managing chronic pain patients prior to the intervention (Polit & 
Beck, 2017).  The same providers were included in the pre- and post-test and there was not a 
control group which will avoid selection bias (Polit & Beck, 2017).  To control for testing bias 
the pre- and post-test were the same and to control for instrumentation bias a validated Likert 
scale for the pre- and post-test was used (Polit & Beck, 2017).   
External validity refers to the degree to which the results of a study can be generalized 
across populations.  To control for this, primary care providers from several different practices 
who see a variety of patients should be included in the study (Polit & Beck, 2017). Additionally, 
the Step Method was reviewed and approved by the CDC (see Appendix E: CDC Response). 
If there is missing or incomplete data, it was acknowledged in the study where limitations 
are discussed.  Available data was analyzed and excluded any missing or incomplete data.  There 
were no call backs.  This is not a blinded study and therefore, not tied to the individual 
participant. 
A data dictionary with all definable data elements was developed.  The dictionary 
explained the contents of the context-specific database. According to American Health 
Information Management Association (AHIMA 2012), “…lack of data consistency can create 
challenges for data comparison and reporting” (p.48).  For these reasons, a table of data 
definitions is included (see Appendix L: Data Dictionary). 
Data Collection/Treatment Procedure 
25 
 
 
 
Participants were recruited via direct contact at a provider meeting at a Denver hospital.  
Project details and rationale were given to the attendees along with instructions for participation.  
Packets with project materials including informed consent were provided for all interested 
providers.  A recruitment flyer was also displayed in the Denver area hospital (see Appendix M: 
Recruitment Flyer). 
The participants were given the informed consent, pre- and post-test, step model, 
education, and module instructions in a self-addressed interoffice mail envelope.  Reminder 
emails were sent mid-February to encourage the participants to continue using the step model 
and to complete the pre-test, consent, and watch the education modules if they had not already 
done so.  They were returned at the end of February through mid-March through interoffice 
mail.   The Likert Scale and true/false questions were developed using the steps described in 
Nursing Research: Generating and Assessing Evidence for Nursing Practice by Polit and Beck, 
2017.  The items included were subjected to internal review by the DNP student and subject 
matter expert mentor.  The items were also evaluated by members of the target population, 
primary care providers.  Items were subjected to review by the expert consulting team to ensure 
validity.  Finally, the reliability of the items was verified using Cronbach’s alpha. 
Project Findings and Results 
Data Analysis and Results 
There were 22 primary care providers who initially agreed to participate in the project 
and of those, there were eight pre-tests returned and seven post-tests returned. The demographic 
data was collected on the pre-test.   For data analysis, the missing data was not included.  100% 
of the participants were physicians (Table 3: Participant Education). The most represented age 
group of the study participants was between 21 and 30 years (n=7) (Table 4: Participant 
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Age). Additionally, 85.7% of the participants were female (Table 5: Participant Gender).  The 
pre-test and post-test consisted of 7 items that could be directly compared.  Again, one case was 
missing so it was excluded in the data analysis.  Cronbach’s Alpha for the 7 items was (α = .892) 
(Table 6: Cronbach’s Alpha Score).  The pre- and post-test were found to be highly reliable.  
Table 3: Participant Education 
Education 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid MD 7 100.0 100.0 100.0 
 
Table 4: Participant Age 
Age 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 21-30 4 57.1 57.1 57.1 
31-40 2 28.6 28.6 85.7 
41-50 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
Table 5: Participant Gender 
Gender 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid male 1 14.3 14.3 14.3 
female 6 85.7 85.7 100.0 
Total 7 100.0 100.0  
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Table 6: Cronbach’s Alpha Score 
 
Reliability Statistics 
Cronbach's 
Alpha 
N of 
Items 
.892 14 
 
Results 
Analysis of the first seven questions of the pre- and post-test was analyzed using the 
Wilcoxon Signed-Ranks Test.  The participants could choose (1) strongly disagree, (2) disagree, 
(3) uncertain, (4) agree, or (5) strongly agree.  They indicated their choice by checking a 
corresponding box.  For these questions n=7.  One post-test score was missing and excluded in 
the analysis. An alpha level of .05 was used for all statistical tests. 
Question one stated:  I have sufficient knowledge to manage chronic, non-malignant pain 
(CNMP) in my primary care practice. The Wilcoxon Signed-Ranks Test indicated post-test ranks 
were statistically significantly higher than the pre-test ranks (Z=21.00, p=.020) for question one 
indicating provider’s perceived knowledge improved after the intervention (Table 7: Wilcoxon 
Question 1).  Analysis of the pre-test descriptive statistics indicated 42.9% were uncertain if they 
had sufficient knowledge to manage chronic, non-malignant pain, 42.9% agreed they had 
sufficient knowledge, and 14.3% felt they did not have sufficient knowledge (Table 8: Pre-test 
Question 1). Post-test analysis displays 71.4% agreed they had sufficient knowledge to manage 
chronic non-malignant pain and 28.6% strongly agreed (Table 9: Post-test Question 1). 
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Table 7: Wilcoxon Question 1 
 I have sufficient knowledge to manage chronic, non-malignant pain (CNMP) in my primary care 
practice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8: Pre-test Question 1   
I have sufficient knowledge to manage chronic, non-malignant pain (CNMP) in my primary care 
practice. 
Pre-test question 1 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid disagree 1 14.3 14.3 14.3 
uncertain 3 42.9 42.9 57.1 
agree 3 42.9 42.9 100.0 
Total 7 100.0 100.0  
 
  
S.D 
4.0 
>-
~ 3.0 
~ 
u.. 2.0 
Related - Samples Wilcoxon Signed Rank Test 
□ ri~i~r Differences 
■ Negative Differences 
(~Nu~6er of Ties "' 1) 
1.0,-+-------< 
o.o,-+---~--+--~----,e--~----1 
.OD .so 1.00 1.50 2.00 2.50 3.00 
Posttest qu estion 1 - Pretest question I 
Total N 7 
Test Statistic 21.000 
Standard Error 4.500 
Standardized Test Statistic 2.333 
Asymptotic Sig. (2 - sided test) .020 
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Table 9: Post-test Question 1 
I have sufficient knowledge to manage chronic, non-malignant pain (CNMP) in my primary care 
practice. 
 
Post-test question 1 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid agree 5 71.4 71.4 71.4 
strongly agree 
2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
Question two states:  I have access to education regarding how to manage opioids for 
CNMP.  The Wilcoxon Signed-Ranks Test indicated post-test ranks were not statistically 
significantly higher than the pre-test ranks (Z=10.000, p=.066) for question two which indicated 
there was no difference in access education between the pre- and post-test scores (Table 10: 
Wilcoxon Question 2).   
Descriptive statistical analysis of pre-test scores indicated 28.6% disagree, in other 
words, they felt they did not have access to education, 14.3% were uncertain if they had access to 
education, and 57.1% agreed they had access to education regarding how to manage opioids for 
CNMP (Table 11: Pre-test Question 2). 
Descriptive statistical analysis of post-test scores displayed 71.4% agreed they had access 
to education regarding how to manage opioids for CNMP and 28.6% strongly agreed.  Although 
the improvement was not statistically significant, it was a positive improvement nonetheless 
from a clinical perspective.  Pre-test scores indicated 42.9% disagreed or were uncertain, post-
test scores highlighted that all the participants felt they had access to education regarding how to 
manage opioids for CNMP (Table 12: Post-test Question 2).   
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Table 10: Wilcoxon Question 2 
I have access to education regarding how to manage opioids for CNMP. 
 
Table 11: Pre-test Question 2 
I have access to education regarding how to manage opioids for CNMP. 
Pre-test question 2 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid disagree 2 28.6 28.6 28.6 
uncertain 1 14.3 14.3 42.9 
agree 4 57.1 57.1 100.0 
Total 7 100.0 100.0  
 
  
Related - Samples Wilcoxon Signed Rank Test 
3.o,-+----~ □ Positive Differences (N=4) 
■ Negative Differences 
(N=0) 
(Number of Ties = 3) 
~2 .0-
~ 
~ [ 
.. 
LO-
o.o,-+-----+-----+-----+--------< 
.00 1.00 2.00 3.00 4.00 
Posttest question 2 - Pretest question 2 
Total N 7 
Test Statistic 10.000 
Standard Error 2.716 
Standardized Test Statistic l.841 
Asymptotic Sig. (2 - sided test) .066 
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Table 12: Post-test Question 2 
I have access to education regarding how to manage opioids for CNMP. 
Post-test question 2 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid agree 5 71.4 71.4 71.4 
strongly agree 
2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
Question three states:  I have confidence in my ability to manage CNMP in primary care.  
The Wilcoxon Signed-Ranks Test indicated that post-test ranks were statistically significantly 
higher than the pre-test ranks (Z=10.000, p=.034) for question three which indicates the 
participants confidence in their ability to manage chronic non-malignant pain improved after the 
intervention (Table 13: Wilcoxon Question 3). 
Descriptive statistical analysis of pre-test scores indicated 87.5% felt a lack of confidence 
in their ability to manage CNMP and 14.3% had confidence in their ability to manage CNMP in 
primary care (Table 14: Pre-test Question 3).  Descriptive statistical analysis of post-test scores 
displayed 28.6% were uncertain of their confidence in their ability to manage CNMP, 42.9% 
agreed and 28.6% strongly agreed they had confidence in their ability to manage CNMP (Table 
15: Post-test Question 3).   
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Table 13: Wilcoxon Question 3 
I have confidence in my ability to manage CNMP in primary care.  
 
Table 14: Pre-test Question 3 
I have confidence in my ability to manage CNMP in primary care.   
Pre-test question 3 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid uncertain 
6 85.7 85.7 85.7 
agree 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
 
 
 
 
4 .0-
3.0-
~ 
~ 
1 2.0 
L O-
Related - Samples Wilcoxon Signed Rank Test 
0 ri! i~)e Oiffer'e nces 
■ Negative Diffe r'e nces 
(~Nu=~ 6 er o f T i es = 2) 
o.o,+ --~---t-----,----+ --~----1 
.00 .SO 1.00 l.SO 2.00 2.SO 3.00 
Posttest question 3 - P rete st question 3 
Total N 7 
Test Statistic 1 5 .000 
Standard Error 3.5 3 6 
Standardized Test Statistic 2.1 2 1 
Asymptotic Sig. (2 - sided test) .034 
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Table 15: Post-test Question 3 
I have confidence in my ability to manage CNMP in primary care.   
Post-test question 3 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid uncertain 2 28.6 28.6 28.6 
agree 3 42.9 42.9 71.4 
strongly agree 
2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
Question four states:  I have a good understanding of the Centers for Disease Control 
(CDC) guidelines (2016) on managing CNMP.  The Wilcoxon Signed-Ranks Test indicated that 
post-test ranks were statistically significantly higher than the pre-test ranks (Z=21.000, p=.023) 
for question four which indicates the participants’ understanding of the CDC guidelines for 
management CNMP improved after the intervention (Table 16: Wilcoxon Question 4). 
Descriptive statistical analysis of pre-test scores indicated that 14.3% strong disagreed 
that they had a good understanding of the CDC guidelines, 57.1% were uncertain, and 28.6% 
agreed they had a good understanding of the CDC guidelines for managing chronic pain in 
primary care (Table 17: Pre-test Question 4). Descriptive statistical analysis of post-test scores 
revealed 14.3% were uncertain if they had a good understanding of the CDC guidelines, 57.1% 
agreed they had a good understanding of the guidelines and 28.6% strongly agreed (Table 18: 
Post-test Question 4). 
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Table 16: Wilcoxon Question 4 
I have a good understanding of the Centers for Disease Control (CDC) guidelines (2016) on 
managing CNMP.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 17: Pre-test Question 4 
I have a good understanding of the Centers for Disease Control (CDC) guidelines (2016) on 
managing CNMP.   
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid strongly disagree 1 14.3 14.3 14.3 
uncertain 4 57.1 57.1 71.4 
agree 2 28.6 28.6 100.0 
4 .0 
l.O 
0 .0 
.00 
Related - Samples Wilcoxon Signed Rank Test 
I I I 
.so l.00 l.SO 2 .00 2 .50 
Posttest question 4 - Pretest question 4 
Total N 
Test Statistic 
Standard Error 
Standardized Test Statistic 
Asymptotic Sig. (2 - sided test) 
D Positive Differences 
(N-6) 
■ Negative Differences 
(N-0) 
(Number of T ies ~ l) 
3.00 
7 
2 1.000 
4 .623 
2 .271 
.023 
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Table 18: Post-test Question 4 
I have a good understanding of the Centers for Disease Control (CDC) guidelines (2016) on 
managing CNMP.   
Post-test question 4 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid uncertain 1 14.3 14.3 14.3 
agree 4 57.1 57.1 71.4 
strongly agree 
2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
Question five states: I am comfortable with where to find the CDC guidelines (2016).  
The Wilcoxon Signed-Ranks Test indicated that post-test ranks were not statistically 
significantly higher than the pre-test ranks (Z=10.000, p=.059) for question five which indicates 
there was no difference in the participants comfort levels in finding the CDC guidelines after the 
intervention (Table 19: Wilcoxon Question 5).  
Descriptive statistical analysis of pre-test scores revealed 14.3% disagree, which means they are 
not comfortable with where to find the CDC guidelines, 87.5% agreed they are comfortable with 
where to find the CDC guidelines (Table 20: Pre-test Question 5).  Descriptive statistical analysis 
of post-test scores indicated 57.1% agreed and 42.9% strongly agreed that they were comfortable 
with where to find the CDC guidelines (Table 21: Post-test Question 5).  Although the difference 
between the pre- and post-test scores was not statistically significant, there was still positive 
improvement from a clinical perspective.  
  
Total 7 100.0 100.0  
Pre-test question 4 
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Table 19: Wilcoxon Question 5  
I am comfortable with where to find the CDC guidelines (2016).   
 
Table 20: Pre-test Question 5 
I am comfortable with where to find the CDC guidelines (2016).   
Pre-test question 5 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid disagree 
1 14.3 14.3 14.3 
agree 6 85.7 85.7 100.0 
Total 7 100.0 100.0  
 
Table 21: Post-test Question 5 
I am comfortable with where to find the CDC guidelines (2016).   
Post-test question 5 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid agree 4 57.1 57.1 57.1 
strongly agree 
3 42.9 42.9 100.0 
Total 7 100.0 100.0  
0.0 
.00 
Related - Samoles Wilcoxon Sianed 
Posnu t quu 1ion S - Prt tu 1 quu 1ionS 
Total N 
Rank Test 
oPositivt Dlfftrtncts (N- 4) 
■ NtgativtDifftrtncts (N- 0) (Numbe r of Ties • 3) 
Tes t Statistic 10.000 
Standard Error 2.646 
Standardized Tes t Statis tic 1.890 
As ymptotic Sig. (2 -sided te s t) .059 
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Question six states: I have a sense of satisfaction when managing CNMP. The Wilcoxon 
Signed-Ranks Test indicated that post-test ranks were statistically significantly higher than the 
pre-test ranks (Z=15.000, p=.038) for question six which indicates the participants sense of 
satisfaction when managing CNMP improved after the intervention (Table 22: Wilcoxon 
Question 6).  
Descriptive statistical analysis of pre-test scores indicated 14.3% strongly disagreed that 
they felt a sense of satisfaction when managing CNMP, 71.4% disagreed, and 14.3% were 
uncertain if they had a sense of satisfaction when managing CNMP (Table 23: Pre-test Question 
6). Descriptive statistical analysis of post-test scores displayed 28.6% disagreed that they felt a 
sense of satisfaction when managing CNMP, 42.9% were uncertain, and 28.6% agreed they had 
a sense of satisfaction when managing CNMP (Table 24: Post-test Question 6).  
 
Table 22: Wilcoxon Question 6 
I have a sense of satisfaction when managing CNMP.  
 
 
 
Related - Samoles Wilcoxon Sianed 
3.0 
LO 
0 .0 
Ran k Test 
0 Posittve Differences 
{N• S) 
■ Ne93tive Diffl!rencM {Na O) 
(Number of Ties • 2) 
.0 0 .50 1.00 l.S0 2.00 2.S0 3.00 
Posnut quu tion 6 - Pr"t1est quu tion 6 
Total N 
Test St.1tis tic 15.000 
Standard Error 3.623 
Standardized Test Statistic 2.070 
Asymptotic Sig. (2 - sid ed test) .038 
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Table 23: Pre-test Question 6 
Pre-test question: I have a sense of satisfaction when managing CNMP.  
Pre-test question 6 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid strongly disagree 
1 14.3 14.3 14.3 
disagree 5 71.4 71.4 85.7 
uncertain 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
Table 24: Post-test Question 6 
I have a sense of satisfaction when managing CNMP. 
 
Post-test question 6 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid disagree 2 28.6 28.6 28.6 
uncertain 3 42.9 42.9 71.4 
agree 2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
Question seven states: My CNMP patients are satisfied with the treatment they receive 
from me.  The Wilcoxon Signed-Ranks Test indicated that post-test ranks were statistically 
significantly higher than the pre-test ranks (Z=10.000, p=.046) for question seven which 
indicates the participants felt their patient’s satisfaction with their treatment for CNMP improved 
after the intervention (Table 25: Wilcoxon Question 7).  
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Descriptive statistical analysis of pre-test scores revealed 14.3% disagreed that their 
patients are satisfied with the treatment they receive, 71.4% were uncertain, and 14.3% agreed 
their patients are satisfied with the treatment they receive (Table 26: Pre-test Question 
7).  Descriptive statistical analysis of post-test scores indicated 42.9% were uncertain and 57.1% 
agree their CNMP patients are satisfied with the treatment they receive (Table 27: Post-test 
Question 7).   
Table 25: Wilcoxon Question 7 
My CNMP patients are satisfied with the treatment they receive from me.   
 
 
Table 26: Pre-test Question 7 
My CNMP patients are satisfied with the treatment they receive from me.   
Pre-test question 7 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid disagree 1 14.3 14.3 14.3 
uncertain 5 71.4 71.4 85.7 
agree 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
i 
4.0-
Related - Samples Wilcoxon Signed Rank Test 
~------,Of~!~~e Differences 
Jo+-------< 
■ ~N'2Mive Differences 
(Number of Ties .. 3} 
! 2.0 
l.0-
o.o+---~----+---~------< 
.00 
Poi;ttutqueition 7- Pretutquution 7 
Total N 
Test Statistic 10.000 
Standard Error 2.500 
Standardized Test Statistic 2.000 
Asymptotic Sig. (2-sided test) .046 
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Table 27: Post-test Question 7 
My CNMP patients are satisfied with the treatment they receive from me.   
Post-test question 7 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid uncertain 3 42.9 42.9 42.9 
agree 4 57.1 57.1 100.0 
Total 7 100.0 100.0  
 
 
There were seven items on the post-test that were not included on the pre-test.  These 
items were directly related to the CDC education module and the step model.  Since these were 
not paired items, descriptive statistics were used to analyze the data.  
Post-test item eight states: the step model increased my understanding of treating CNMP.  
85.7% agreed and 14.3% strongly agreed with this statement (Table 28: Post-test Question 
8).  Post-test item nine states: The CDC education modules increased my understanding of 
opioids. 71.4% agree and 28.6% strongly agree with this statement (Table 29: Post-test Question 
9).  Post-test item ten states: The CDC education modules increased my understanding of the 
CDC guidelines.  71.4% agree and 28.6% strongly agree with this statement (Table 30: Post-test 
Question 10). Post-test item 11 states: I referred to the step model for guidance when treating 
patients with CNMP. 28.6% were uncertain, 57.1% agreed, and 14.3% strongly agreed with this 
statement (Table 31: Post-test Question 11). Post-test item 12 states: The step model helped me 
when treating patients with CNMP. 28.6% of the participants were uncertain and 71.4% agreed 
with this statement (Table 32: Post-test Question 12). Post-test item 13 states: I would 
recommend the step model to my colleagues. 71.4% of the participants agreed and 28.6% 
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strongly agreed (Table 33: Post-test Question 13). Finally, post-test item 14 states:  I would 
recommend the CDC education modules to my colleagues. 57.1% of the participants agreed and 
42.9% strongly agreed (Table 34: Post-test Question 14).  Overall the feedback from the 
participants about the step model and the education modules was positive indicating they were 
helpful.  
Table 28: Post-test Question 8 
The step model increased my understanding of treating CNMP.   
Post-test question 8 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid agree 6 85.7 85.7 85.7 
strongly agree 1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
Table 29: Post-test Question 9 
The CDC education modules increased my understanding of opioids. 
Post-test question 9 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid agree 5 71.4 71.4 71.4 
strongly 
agree 2 28.6 28.6 100.0 
Total 7 100.0 100.0  
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Table 30: Post-test Question 10 
The CDC education modules increased my understanding of the CDC guidelines.   
Post-test question 10 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid agree 5 71.4 71.4 71.4 
strongly 
agree 
2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
Table 31: Post-test Question 11 
I referred to the step model for guidance when treating patients with CNMP. 
Post-test question 11 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid uncertain 2 28.6 28.6 28.6 
agree 4 57.1 57.1 85.7 
strongly agree 
1 14.3 14.3 100.0 
Total 7 100.0 100.0  
 
Table 32: Post-test Question 12 
The step model helped me when treating patients with CNMP.  
Post-test question 12 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid uncertain 
2 28.6 28.6 28.6 
agree 5 71.4 71.4 100.0 
Total 7 100.0 100.0  
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Table 33: Post-test Question 13 
I would recommend the step model to my colleagues. 
Post-test question 13 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid agree 5 71.4 71.4 71.4 
strongly agree 
2 28.6 28.6 100.0 
Total 7 100.0 100.0  
 
 
Table 34: Post-test Question 14 
I would recommend the CDC education modules to my colleagues. 
Post-test question 14 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid agree 4 57.1 57.1 57.1 
strongly 
agree 
3 42.9 42.9 100.0 
Total 7 100.0 100.0  
 
Descriptive statistics were used to analyze the true/false items.  Items one through seven 
were on both the pre- and post-test.  Items eight and nine were only on the post-test since they 
only pertained to the intervention.  There was minimal change in the overall prescribing habits of 
the sample providers as measured with the true/false questions.   
The most significant items on this portion of the questionnaire were the responses for 
items seven through nine.  Item seven states, I use the CDC guidelines (2016) for CNMP.   The 
pre-test scores indicated that 42.9% of the participants used the CDC guidelines and 57.1% did 
not use the CDC guidelines before the intervention.   After the intervention all of the participants 
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used the guideline, 100% (Table 35: Pre-test Use CDC Guidelines, Table 36: Post-test Use CDC 
Guidelines, Table 37: Pre-test Use CDC Guidelines Bar Chart, Table 38: Post-test Use CDC 
Guidelines Bar Chart). Item eight states: the step model helped me treat patients with 
CNMP.  All of the participants felt the step model helped them treat CNMP (Table 39: Post-test 
Step Model Useful). Finally, item nine reads: the CDC education modules (2017) helped me treat 
patients with CNMP.  Again, all of the participants felt the education modules helped them when 
treating CNMP (Table 40: Post-test Education Module Useful). 
Table 35: Pre-test Use CDC Guidelines 
Pre-CDC guidelines 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid true 3 42.9 42.9 42.9 
false 4 57.1 57.1 100.0 
Total 7 100.0 100.0  
 
Table 36: Post-test use CDC guidelines 
Post-CDC guidelines 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid true 7 100.0 100.0 100.0 
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Table 37: Pre-test use CDC Guidelines Bar Chart 
  
 
 
 
Table 38 Post-test use CDC Guidelines Bar Chart
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Table 39 Post-test Step Model Useful 
Step model 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid true 7 100.0 100.0 100.0 
 
Table 40 Post-test Education Modules Useful 
Education module 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid true 7 100.0 100.0 100.0 
 
The final analysis of the project data suggests the education module and step model 
increased knowledge and confidence in managing CNMP and prescribing opioid medication for 
this population.  It also demonstrated a lack of education related to management of CNMP and 
opioid medications highlighting the need for increased education on chronic pain management 
and opioid therapy for physicians in the sample population. 
The step model developed for this project was helpful as a visual representation of the 
CDC guidelines on prescribing opioids for chronic pain in the primary care setting for the sample 
population.  This project exhibited the benefit of having a tool that is easily accessible and easily 
comprehended which could help with evidenced based management of chronic pain.  
The mission of this project was to provide education and easily accessible and 
comprehensible guidance for primary care providers in managing chronic, non-cancer pain 
utilizing the updated CDC guidelines.  Although there was a small sample, the results suggest the 
mission was achieved.   
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 The vision of the project was to improve provider satisfaction in caring for patients with 
chronic, non-cancer pain as well as improving patient outcomes by utilizing best practices.  The 
results of the project support the vision for this project was achieved.     
Limitations 
There were several limitations noted for this study.  The first, and probably most 
significant, is the small sample size.  The project materials were given to 22 primary care 
providers with only seven returned. Additionally, the study was conducted only in the Centura 
Health System, north metro Denver area.  The homogeneity of the sample group may not 
account for factors that could change the outcomes.  The study is not transferable to other 
locations based on the small sample size. 
Additionally, there were no nurse practitioners who returned the project materials for 
analysis.  The homogeneity of the sample does not allow for generalization to all primary care 
providers.  Finally, due to the academic nature of this project, time constraints for data collection 
limited the number of participants.  A repeat study with a larger sample population and more 
participants might produce stronger data for practice improvement.    
Recommendations 
Repeating the study with at least 50% nurse practitioners or even, 100% nurse 
practitioners could highlight the potential educational gap in nurse practitioner programs.  While 
the data indicated statistically significant improvement in several areas in the sample population, 
the results cannot be generalized to all primary care providers. Additional research about the 
utilization of the Step Model is recommended. Additionally, a larger recruitment area could 
increase heterogeneity and therefore allow for increased reliability and adaptability of the 
model.   
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Implications for Change 
Further studies might elicit more information from providers on personal prescribing 
habits to account for factors influencing prescribing other than knowledge and confidence plus 
what role the lack of knowledge and confidence of the providers plays in the current opioid 
crisis. Determining if primary care providers are indeed prescribing opioids inappropriately will 
be difficult due to the lack of agreed upon guidelines, subjective nature of chronic pain, and 
personal philosophy. Prescribing is largely based on individual clinical decision making.   
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Appendix B 
Timeline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pro1«t o~efopment 
-
PrOJK1 mp&cmC'nl~IIOll 
Development: July 2016 to May 2017 
IRB Submission: September 2017 to November 2017 
Implementation: December 2017 to February 2018 
Data Analysis: March 2018 
Disseminate Findings: April 2018 
Defense of Project: April 2018 
Dissemination to Library: April 2018 
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Appendix C 
Budget 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost Category Description Total Cost 
Primary Care Providers Time spent on surveys 
(Based on goal of 20 and education module $2,000.00 
at $SO/hour (2-hour participants) 
average). 
Time spent designing 
project and education 
Project Researchers module and data $10,000.00 
analysis at $SO/hour 
(approximately 200 
hours) . 
Step model and 
Printing Costs questionnaires @ Est. $50.00 
0.10/page 
Statistical analysis SPSS $60.00 
software 
Storage Box To keep Est. $50.00 
questionnaires locked 
Data analysis at 
Statistician approximately Est. $150.00 
$SO/hour for 3 hours 
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Appendix D 
CDC Education Modules 
 
Addressing the Opioid Epidemic: Recommendations from CDC 
WB2857 
Module1 
PROGRAM DESCRIPTION: This module will look at the CDC recommendations 
regarding the prescription of opioids for chronic pain. Given that it is sometimes hard to 
determine when acute pain becomes chronic pain, recommendations are also ilduded 
related to prescribilg opioids for acute pain. You will have the opportunity to examine 
the implications of these recommendations for treating your patients, and to practice 
making the best choices for their overall health and well-being. 
Please refer to the CDC Guidelne for PrescrlJing Opioids for Chronic Pain for additional 
ilformation as needed during this training. 
OBJECTIVES: 
At the condusion of the session, the participant will be able to: 
1) Explain why a guideline for prescribing opioids is needed 
2) Describe the key recommendations in the CDC guideline for prescribing opioids 
3) Explain potential benefits of implementing the CDC recommendations for prescribilg 
opioids 
FACULTY/ CREDENTIALS: 
Deborah Dowell, MD, MPH 
Senior Medical Advisor, Division of Unintentional Injury Prevention 
National Center for Injury Prevention and Control (NCIPC) 
Centers for Disease Control and Prevention (CDC) 
Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH) 
Debra Houry, MD, MPH 
Director 
National Center for Injury Prevention and Control (NCIPC) 
Centers for Disease Control and Prevention (CDC) 
Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH) 
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Treating Chronic Pain Without Opioids 
WB2859 
Module2 
PROGRAM DESCRIPTION: This module will look at the CDC recommended options 
for treating chronic pain without opioids. You \Nill have the opportunity to examine the 
benefits and expected outcomes of prescribing nonopioid medications and 
nonpharmacologic treatments to your patients. 
Please refer to the CDC Guideline for Prescribing Opioids for Chronic Pain for additional 
information as needed during this training. 
OBJECTIVES: 
At the conclusion of the session, the participant will be able to: 
1) Recognize that nonopioid medications and nonpharmacologic treatments are the 
preferred methods for treating chronic pain 
2) Describe co1TTI1unication techniques that facilitate a patient-centered approach to 
manage chronic pain 
3) Describe risks and benefits of first-line treatments for chronic pain 
4) Identify nonopioid medications for various types of chronic pain 
5) Identify nonpharrnacologic treatment options for various types of chronic pain 
FACULTY/ CREDENTIALS: 
Deborah Dowell, MD, MPH 
Senior Medical Advisor, Division of Unintentional Injury Prevention 
National Center for Injury Prevention and Control (NaPC) 
Centers for Disease Control and Prevention (CDC) 
Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH) 
ORIGINATION DA TE: 
EXPIRATION DA TE: 
URL: 
HARDWARE/SOFlWARE: 
August 4, 2017 
August 4, 2019 
https1/www.cdc.gov/drugoverdose/training/nonopioid 
Computer Hardware; Internet connection; Browser 
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Appendix E 
CDC Response to Step Model 
 
From: Dow ell, Deborah (Debbie) (CDC/ONDIEH/NCIPC) gdo7@cdcgov 
Subject: RE: Research question 
Date: November 17, 2017 at 9:06 AM 
To: Smith, Melissa J msmIth036@regIs edu 
Hi Melissa , 
Sorry for my long delay in responding to this. I rece ived your voicemail earlier this week. 
I think the step model you sent makes sense and has value. It also fa irly accurately 
reflects the recommendations in the 2016 CDC Guideline for Prescribing Opioids for 
Chronic Pain. There are just 2 modifications I'd suggest if you want it to align more 
completely with CDC's Guideline: 
I. We did not specifically state that patients on :::. 90 MME/day of opioids needed to 
be referred to a pain special ist, although we suggested it as a consideration. 
Other guidelines have made a stronger recommendation on this, and we 
considered it, but we decided not to because of concerns about inadequate 
access to pain specialists in many areas and because it would not be certain that 
every pain specialist would always carefully evaluate benefits and risks consistent 
with the evidence summarized in the Guideline. Instead, we recommended 
avoiding or carefully justifying increasing opioid dosage to 90 MME or more. We 
noted that justification could include the following facto rs: "individualized assessment 
of benefits and risks and weighing factors such as di agnosis, incremental benefits for pain 
and function relative to harms as dosages approach 90 M:ME/day, other treatments and 
effectiveness, and recommendations based on consul tation wi th pain specialists". For 
patients already rece iving high dosages of opio ids, we recommended that "patients 
should be offered the opportuni ty to re-evaluate their continued use of opioids at high 
dosages in light of recent evidence regarding the association of opi oid dosage and 
overdose risk. Clinicians should explain in a nonj udgmental manner to patients already 
taking high opioid dosages (::::90 M:ME/day) that there is now an established body of 
scientific evidence showing that overdose ri sk is increased at higher opioid dosages. 
Clinici ans should empathically review benefits and risks of continued high-dosage opioid 
therapy and should offer to work with the patient to taper opioids to safer dosages. For 
patients who agree to taper opioids to lower dosages, clini cians should collaborate with the 
patient on a tapering pl an." 
2. This is a very minor point, but we did not include massage in recommended 
nonopioid treatments for pain in the Guideline, because we did not find studies 
documenting long-term efficacy. However, it is very unlikely that massage will 
harm patients and it may help some, so I think reasonable to include among 
suggested approaches. 
Thank you for undertaking this important work! 
Best wishes, 
Debbie 
Deborah Dowell, MD, MPH 
CDR, US Public Health Service 
Senior Medical Advisor, Division of Unintentional Injury Prevention 
CDC - National Center for Injury Prevention and Control 
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Appendix F 
Conceptual Model 
 
 
 
 
 
 
 
 
Appendix G 
Logic Model Development 
Program Planning Template 
Strategies 
Create a step model for managing chronic pain patients in the primary care 
setting. 
• Create an online learning video to instruct primary care providers how to use 
the model and how and when to prescribe opioids safely. 
5 
lnfluentlal Factors 4 Problem or Issue 
Assumptions 
The hospital and primary care providers will support efforts to improve patient 
care, increase provider knowledge and confidence, and reduce opioid burden in 
the community by a reduction in inappropriate prescribing practices. 
Primary care providers will agree to participate in education of step model. 
• Increasing knowledge and confidence of primary care providers in chronic pain 
management will improve patient outcomes, increase provider satisfaction, and 
reduce opioid burden in the community. 
6 
Access to primary care 
providers through hospital 
network.. 
Lack of knowledge and confidence in managing chronic 
pain patients by primary care providers. 
Desired Results 
(outputs, outcomes, 
and Im act 3 
Primary care providers are 
fearful of patient harm and 
scrutiny from regulatory 
agencies, knowledge gaps, 
and Jack formal medical 
training to prepare them to 
manage chronic pain 
effectively. 
Primary care providers lack 
of willingness to devote 
time to learning step model. 
Patients are not treated for chronic pain according to 
guidelines and best practice, especially when prescribing 
opioids. 
Patients have untreated or undertreated chronic pain. 
Primary care providers experience less job satisfaction. 
Community Needs/Assets 
Colorado is second highest in country for nonmedical use 
of prescription opioids. 
Patients are treated inappropriately, increasing potential or 
misuse or abuse of opioids. 
Inappropriate prescribing of opioids contributes to the 
current opioid epidemic. 
Evaluation Logic Model Guide, W.K. Kellogg Foundation, Page 57 
Increased knowledge and 
confidence in managing 
chronic pain patients by 
primary care providers. 
Improved patient outcomes 
by using step model. 
Reduction in inappropriate 
prescribing of opioids for 
chronic pain. 
Reduction in overall pill 
burden in community. 
• Primary care providers 
experience increased job 
satisfaction. 
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REGIS~UNIVERSITY 
DATE: 
TO: 
FROM: 
PROJECT TITLE: 
SUBMISSION TYPE: 
ACTION: 
DECISION DATE: 
REVIEW CATEGORY: 
REGIS .EDU 
Institutional Review Board 
October 17, 2017 
Melissa Smith, MSN 
Regis University Human Subjects IRB 
[1121681-1] Step model for managing chronic, non-cancer pain in primary 
care 
New Project 
DETERMINATION OF EXEMPT STATUS 
October 17, 2017 
Exemption category # (7) 
Thank you for your submission of New Project materials for this project. The Regis University Human 
Subjects IRB has determined this project is EXEMPT FROM IRB REVIEW according to federal 
regulations 45.CFR46.101 (b). 
We will retain a copy of this correspondence within our records. 
If you have any questions, please contact the Institutional Review Board at im@regis.edu. Please include 
your project title and reference number in all correspondence with this committee. 
This letter has been electronically signed in accordance with all applicable regulations, and a copy is retained within Regis University 
Human Subjects IRB's records. 
-1- Generated on IRBNet 
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Appendix H 
Catholic Health Initiatives (CHI) IRB Exempt Letter 
 
.... 
""r CHI Institute for 
Research and Innovation 
DATE: December 5, 2017 
TO: Melissa Smith , DNPc 
FWA Number: FWA 00019514 
OHRP IRB Number: IRB00009715 
PROJECT TITLE : [1146024-1] Step model for managing chron ic, non-cancer pain in primary 
care 
SUBMISSION TYPE: 
ACTION: 
DECISION DATE: 
REVIEW TYPE: 
REVIEW CATEGORY: 
New Project 
DETERMINATION OF EXEMPT STATUS 
November 27, 2017 
Exempt Review 
Exemption category # 1, 2 
Thank you for your submission to the Catholic Health Initiatives Institute for Research and Innovation 
Institutional Review Board (CHIRB). An individual designated by the CHIRB detennined this project to be 
EXEMPT FROM IRB REVIEW according to lederal regulations. The following documents were reviewed 
in making this detennination of exemption: 
• AbstracUSummary - MelissaSmithFCOIDisclosure (UPDATED: 10/21/2017) 
• AbstracUSummary - IRBnet Exempt Approval.pdf (UPDATED: 10/21/2017) 
• AbstracUSummary -Adult lnfonned Consent Fonn Centura.docx (UPDATED: 10/21/2017) 
• AbstracUSummary- Recruitment Flyer Final.pdf (UPDATED: 10/21/2017) 
• AbstracUSummary-CDC training video module 1.pdf(UPDATED: 10/21/2017) 
• AbstracUSummary - CDC training video module 2.pdf (UPDATED: 10/21/2017) 
• AbstracUSummary- Pre-Test Questions Final.docx (UPDATED: 10/21/2017) 
• AbstracUSummary - Post Test Questions final.docx (UPDATED: 10/21/2017) 
• AbstracUSummary - Centura Approval.pdf (UPDATED: 10/21/2017) 
• Advertisement- CHIRB lnfonnation Sheet - Recruitment Script v. "ll FEB 2015.docx (UPDATED: 
10/21/2017) 
• AmendmenUModification - Dowell Response PDF.pdf (UPDATED: 11/26/2017) 
• AmendmenUModification -Appendix C Step Model 1.4 PDF.pdf (UPDATED: 11/26/2017) 
• Application Form - Expedited Regis University Application (UPDATED: 10/21/2017) 
• CHI - Research Application -CHI - Research Application (UPDATED: 10/21/2017) 
Should you wish to amend this project in any way that might impact this exempt determination, please 
contact the CHIRB. Please note that all personnel who will interact with research subjects or access 
identifiable data wil need to have completed HIPAA and human subject protection courses as specified in 
the CIRI Research Education Plan prior to initiating research activities. For assistance, contact the CHIRB 
or the CIRI Training Manager. Please also note that the Pl must maintain documentation of all required 
personnel trainings, and understands that training records, among other study documents, are auditable. 
- 1 - ()l:rac1o1f:c:d on l t UNct 
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Appendix I 
CITI Certifications 
 
 
 
1~CITI 
,~ PROGRAM 
This is to certify that: 
Melissa Smith 
Has completed the following CITI PfOgram course: 
The RCR for Social & Behavioral (Curriculum Group) 
The RCR for Social & Behavioral (Course Leamer Group) 
1 - RCR (Stil&el 
Under requirements set by: 
Regis University 
Completion Date 21-Aug-2017 
Expiration Date 20-Aug-2020 
Record JO 24256766 
CITI 
Verify at V\WW.citiprogram.org/verifyf'w93c7e529-d214-43e0-aac4-0ec4d06Sb224-24256766 
~CITI 
~ PROGRAM 
Completion Date 21-Aug-2017 
Expiration Date NIA 
Record JO 24256769 
This is to certify that: 
Melissa Smith 
Has completed the following CITI Program course: 
Information Privacy & Security (Currkulum Group) 
Researche,rs (IPS) {C"Olir<.I" 1 P.lrnerGroup) 
1 ~ Basic Course 
Under rcquircmcnt5 set by: 
Regis University CI,r, ,. 
Collabor~rive, lf!srnut:onal Tra1nt:1g 1n:ti.Jtive 
verify at www.citiprogram.org/verify/?w1 a331 a 19-57a8-400a-8379-aea6c426c532-24256769 
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-1CITI 
" PROGRAM 
This is to certify that: 
Melissa Smith 
Has completed the following CITI Program course: 
Human Research 1cumcutumGl"oup) 
Biomedical Research Investigators and Key Personnel ccou1'$el.Nme1"GroupJ 
2 • Refresher Course (St.1geJ 
Under requirem ents set by: 
Regis University 
Completion Date 21-Aug-2017 
Expiration Date 20-Aug-2020 
Record 1D 24256765 
Collabor.i:'..!Ye n'>L tub:ma! Tr.arrt.ng nmat1·.-e 
Verify at www.citiprogram.org/Verifyf?wb81 eabbb-2801-4dce-9c5d-572c752f3bc0-24256765 
-1CITI 
\~ PROGRAM 
This is to certify that: 
Melissa Smith 
Has completed the following CITI Program course: 
Social & Behavioral Research - Basic/Refresher ccunicuhJfflGroup> 
Social & Behavioral Research (HSR) (CourH LHrn«Group) 
2 - Refresher Course 
Under requirements set by: 
Catholic Health Initiatives 
Completion Date 04-Sep-2017 
Explra llon Date 03-Sep-2020 
Record 10 24459607 
Verify a t www.citiprogram.org/verify/?wl 273e73 l-9fl f-4d6b-b4bd-c1 969febbb6d-24459607 
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.t~CITI 
~ PROGRAM 
This is to certify that: 
Melissa Smith 
Has completed the following CITI Program course: 
CITI Conflicts of Interest (Curriculum Group) 
Conflicts of Interest (CourseLearMrGroup) 
1 - Stage 1 (Sta5e) 
Under requirements set by: 
Catholic Health Initiatives 
Completion Date 04-Sep-2017 
Expiration Date 03-Sep-2021 
Record 10 24459609 
CITI 
Verify at www.citiprogram.org/verifyl?wb3e4c571 -3ab0-49f4-a 1ec-f8df316a8f15-24459609 
.t~CITI 
~ PROGRAM 
This is to certify that: 
Melissa Smith 
Has completed the following CITI Program course: 
Responsible Conduct of Research (RCR) (Cum<.ulum Group) 
Completion Date 04-Sep-2017 
Expiration Date 03-Sep-2020 
Record ID 24459606 
Social-Behavioral -Educational Researchers (RCR) (Course- Le.irner Group) 
2 - RCR Refresher (Slagel 
Under requirements set by: 
Catholic Health Initiat ives CITI 
Collabora:Ne 1nst1tut10.1.1I Training In uotive 
Verify at www.ctiprogram.org/verifyf'w94effe07-e52d-4f33-adf3-437f6b99a4e5•24459606 
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Appendix J 
Pre-test Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-test Questions 
Code mnnber: 
INSTRUCilONS: Please ra1e bow strongly you agree or disagree with each of the following statements by 
circling the appropriate number. 
1- 2- 5-
strongly disagree 3 - lJIICertain 4- agree strongly disagree agree 
1. I have sufficient knowledge 
to manage chronic, non-
D1 D 2 03 0 4 Os 
malignant pain (CNMP) in 
my primary care practice. 
2. I have access to education 
regarding how to manage □1 □2 03 0 4 Os 
opioim for CNMP. 
3. I have confidence in my 
ability to manage CNMP in □1 □2 03 0 4 Os 
primary care. 
4. I have a good understanding 
of the Centers for Disease D1 D 2 03 0 4 Os Control (CDC) guidelines 
(2016) on managing CNMP. 
5. I am comfortable with where 
to find the CDC guidelines D1 D 2 03 0 4 Os 
(2016). 
6. I have a sense of satis:laction □1 □2 03 0 4 Os when managing CNMP. 
7. My CNMP patients are 
satisfied with the treatment D1 D 2 03 0 4 Os 
they receive from me. 
Continued on next page 
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INSTRUCTIONS: Read each statement. Circle true if the statement applies to your practice or false if the 
statement does not apply to your practice_ 
L I prescribe opioids for CNMP_ □True □False 
2_ I prescribe :'.S 50 morphine milligram equivalents (MME) per day for □True □False CNMP_ 
3_ I prescribe between 50 MME and :'.S 90 MME per day for CNMP_ □True □False 
4_ I prescribe > 90 MME per day for CNMP_ □True □False 
5_ I prescribe non-opioid medications for CNMP_ □True □False 
6_ I prescribe multidisciplinary interventions for CNMP_ □True □False 
7_ I use the <DC guidelines {2016) for CNMP_ [Jrrue □False 
Comments: 
Please describe your unique attitude toward managing the chronic pain patient in the primary care setting_ 
Please check your educational preparation: D MD D Resident D NP OPA 
Age range: D21-30 D 31-40 D41-50 051-60 061-70 
Gender: Dmale □female 
67 
 
 
 
Appendix K 
Post-test Questionnaire 
 
Post-test Questions 
Code number: 
INSTRUCTIONS: Please rate how strongly you agree or disagree with each of the following statements by 
circling the appropriate number. 
1- 2- 5-
strongly disagree 3 - uncertain 4 - agree strongly disagree ae.ree 
1. I have sufficient knowledge 
to manage chronic, non-
01 02 03 04 05 
malignant pain (CNMP) in 
my primary care practice. 
2. I have access to education 
regarding how to manage 01 02 03 04 05 
opioids for CNMP _ 
3. I have confidence in my 
ability to manage CNMP in 01 02 03 04 05 
primary care. 
4. I have a good understanding 
of the Centers for Disease 01 02 03 04 05 Control (CDC) guidelines on 
managing CNMP (2016). 
5. I am comfortable with where 
to find the CDC guidelines 01 02 03 04 05 
(2016). 
6. I have a sense of satisfilction 
01 Oz 03 04 05 
when managing CNMP. 
7. My CNMP patients are 
satisfied with the treatment 01 02 03 04 05 
they receive from me. 
8. The step model increased my 
understanding of treating 01 02 03 04 05 
CNMP. 
9. The CDC education modules 
(2017) increased my 01 02 03 04 05 
understanding of opioids. 
10. The CDC education modules 
(2017) increased my 
01 02 03 04 05 
understanding of the CDC 
guidelines (2016). 
11. I referred to the step model 
for guidance when treating 01 02 03 04 05 
patients with CNMP _ 
68 
 
 
 
 
12. The step model helped me 
when treating patients with 01 02 03 04 □5 
CNMP. 
13. I would recommend the step 
D1 02 03 04 □5 model to my colleagues. 
14. I would recommend the COC 
education modules {2017) to D1 02 03 04 □5 
my colleagues. 
INSTRUCTIONS: Read each statement. Circle true if the statement applies to your practice or false if the 
statement does not apply to your practice. 
L I prescribe opioids for CNMP. □True 0False 
2. I prescribe :S 50 morphine milligram equivalents (MME) per day for □True □False CNMP. 
3. I prescribe between 50 MME and :S 90 MME per day for CNMP. □True 0False 
4. I prescribe > 90 MME per day for CNMP. □True □False 
5. I prescribe non-opioid medications for CNMP. □True □False 
6. I prescribe multidisciplinary interventions for CNMP. □True □False 
7. I use the COC guidelines (2016) for CNMP. □True □False 
8. The step model helped me treat patients with CNMP. □True 0False 
9. The CDC education modules (2017) helped me treat patients with □True □False CNMP. 
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Comments: 
Please describe your unique attitude toward managing the chronic pain patient in the primary care setting has or 
has not changed since completing the education modules. 
Please describe your unique attitude toward managing the chronic pain patient in the primary care setting has or 
has not changed since using the step model or why not using. 
Please check your educational preparation: D MD D Resident D NP 0 PA 
Age range: D21-30 D 31-40 D 41-50 051-60 0 61-70 
Gender: Dmale □female 
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Appendix L 
Data Dictionary 
Table Field Data Type Description 
Provider   Include MD, 
Resident, NP, or 
PA currently 
practicing in the 
primary care 
setting in the 
Centura Hospital 
System.  
Provider PROVIDER_ID Integer Unique number 
given to each 
provider. 
Provider PROVIDER_TYPE Integer A unique ID for 
each specialty:1- 
MD, 2-Resident, 
3-NP or 4-PA. 
Age Range AGE Integer Age range:  1- 21-
30;  2- 31-40; 3-
41-50; 4- 51-60; 5-
61-70 
 
Pre-Test   A Likert-scale test 
and true/false 
questions to be 
administered 
before the 
education module 
and introduction to 
step-model.  
Pre-Test PREQUESTION_1 - 7 Integer  A unique response 
for each question 
numbered 1-7 for 
each provider. 
Pre-Test PREQUESTION_1-7 Category True/false 
response for each 
question numbered 
1-7 for each 
provider. 
Pre-Test PREQUESTION_COMMENT Text An open-ended 
question to allow 
for the participant 
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to describe their 
unique attitudes 
toward managing 
the chronic pain 
patient in the 
primary care 
setting.  
 
Post-Test   A Likert-scale test 
and true/false 
questions to be 
administered after 
the education 
module and 
introduction to 
step-model.  
Post-Test POSTQUESTION_1-14 Integer A unique response 
for each question 
number 1-14 for 
each provider. 
Post-Test PostQUESTION_1-9 Category True/false 
response for each 
question numbered 
1-9 for each 
provider. 
Post-Test POSTQUESTION_COMMENT Text An open-ended 
question to allow 
for the participant 
to describe their 
unique attitudes 
toward managing 
the chronic pain 
patient in the 
primary care 
setting.  
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Appendix M 
Recruitment Flyer 
 
 
 
 
A doctoral project practice improvement study for the management of 
chronic, non-cancer pain in primary care practice 
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The benefits of 
participation are: 
• Increasing your knowledge 
concerning managing chronic, 
non-cancer pain. 
• Increased knowledge and 
understanding of the CDC 
guidelines for opioid prescribing. 
• Earn CME credits with completion 
of the online learning module. 
Risks of participation: 
If you are interested in participating or 
would like more information regarding 
this study please contact the researcher, 
Melissa Smith, DNPc via phone or email 
at: 
msmith036@regis.edu 
or 317-664-1998 
